Osaic Holdings
MIRM icon

Osaic Holdings’s Mirum Pharmaceuticals MIRM Stock Holding History

Osaic Holdings’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.68M Buy
14,312
+12,559
+716% +$1.26M ﹤0.01% 2473
2026
Q1 		$162K Buy
1,753
+175
+11% +$16.5K ﹤0.01% 4320
2025
Q4 		$125K Buy
1,578
+458
+41% +$32.9K ﹤0.01% 4523
2025
Q3 		$82.5K Buy
1,120
+14
+1% +$890 ﹤0.01% 4941
2025
Q2 		$56.3K Buy
1,106
+351
+46% +$15.6K ﹤0.01% 4965
2025
Q1 		$34K Sell
755
-401
-35% -$18.9K ﹤0.01% 4989
2024
Q4 		$47.8K Sell
1,156
-26,129
-96% -$1.09M ﹤0.01% 4739
2024
Q3 		$1.06M Buy
27,285
+26,107
+2,216% +$1.04M ﹤0.01% 2196
2024
Q2 		$40.3K Buy
1,178
+428
+57% +$11.2K ﹤0.01% 4846
2024
Q1 		$18.8K Sell
750
-179
-19% -$4.92K ﹤0.01% 5403
2023
Q4 		$27.4K Sell
929
-689
-43% -$20.9K ﹤0.01% 5310
2023
Q3 		$51.1K Buy
1,618
+1,587
+5,119% +$43.5K ﹤0.01% 4994
2023
Q2 		$801 Buy
+31
New +$824 ﹤0.01% 6940

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings's MIRM Position: Q2 2026 in Review

Osaic Holdings increased its Mirum Pharmaceuticals (MIRM) stake by 716% in Q2 2026, buying an estimated $1.26M and bringing the position to 14,312 shares worth $1.68M. The position accounts for ﹤0.01% of the portfolio, ranked #2473.

Osaic Holdings first reported a position in MIRM in Q2 2023 and has held it in 13 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Osaic Holdings held 14,312 shares of Mirum Pharmaceuticals worth $1.68M as of Q2 2026.
  • Osaic Holdings bought 12,559 Mirum Pharmaceuticals shares in Q2 2026, an estimated $1.26M.
  • Mirum Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #2473 holding.
  • Osaic Holdings first reported a position in Mirum Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.